Skip to content
10-Q

Quarterly Report

SAFECODE DRUG TECHNOLOGIES CORP.

0001144204-13-027665

← back to feed
Filed
May 10, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Mar 31, 2013 107.58M sh
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$207.42K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$336.7K
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$1.08K
Cash And Equivalents Q1 2013 · Mar 31, 2013 $0
Cash And Equivalents Q1 2013 · Dec 31, 2012 $0
Cash And Equivalents Q1 2013 · Mar 31, 2012 $103.7K
Cash And Equivalents Q1 2013 · Dec 31, 2011 $0
Cash And Equivalents Q1 2013 · Nov 22, 2010 $0
Stockholders Equity Q1 2013 · Mar 31, 2013 −$37.32K
Stockholders Equity Q1 2013 · Dec 31, 2012 $112.66K
Stockholders Equity Q1 2013 · Dec 31, 2011 −$50.62K
Stockholders Equity Q1 2013 · Dec 31, 2010 −$11.76K
Stockholders Equity Q1 2013 · Nov 22, 2010 $0
Current Liabilities Q1 2013 · Mar 31, 2013 $162.39K
Current Liabilities Q1 2013 · Dec 31, 2012 $61.67K
Total Liabilities Q1 2013 · Mar 31, 2013 $162.39K
Total Liabilities Q1 2013 · Dec 31, 2012 $61.67K
Current Assets Q1 2013 · Mar 31, 2013 $15.07K
Current Assets Q1 2013 · Dec 31, 2012 $174.33K
Total Assets Q1 2013 · Mar 31, 2013 $125.07K
Total Assets Q1 2013 · Dec 31, 2012 $174.33K
Net Income Q1 2013 · Mar 31, 2013 −$562.99K
Net Income Q1 2013 · Mar 31, 2013 −$2.68M
Net Income Q1 2013 · Dec 31, 2012 −$2.06M
Net Income Q1 2013 · Mar 31, 2012 −$654
Net Income Q1 2013 · Dec 31, 2011 −$41.86K
Net Income Q1 2013 · Dec 31, 2010 −$11.76K
Operating Income Q1 2013 · Mar 31, 2013 −$505.22K
Operating Income Q1 2013 · Mar 31, 2013 −$2.6M
Operating Income Q1 2013 · Mar 31, 2012 −$6.47K
Revenue Q1 2013 · Mar 31, 2013 $0
Revenue Q1 2013 · Mar 31, 2013 $0
Revenue Q1 2013 · Mar 31, 2012 $0